Who owns Protalix Biotherapeutics Inc?
- Ticker: PLX
- CUSIP Number: 74365a309
Tip: Access positions for across all investors
Analyze quarterly positions in Protalix Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Protalix Biotherapeutics stock
Who bought or sold Protalix Biotherapeutics Inc this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| Renaissance Technologies | 1.1M | $2.1M | 17% | Dec 2024 |
|
| Northern Trust | 732k | $1.4M | 1299% | Dec 2024 |
|
| Millennium Management | 388k | $729k | 4% | Dec 2024 |
|
| GSA Capital Partners | 306k | $575k | -30% | Dec 2024 |
|
| Stratos Wealth Partners | 270k | $508k | 0% | Dec 2024 |
|
| BlackRock | 225k | $422k | 26% | Dec 2024 |
|
| Citadel Advisors | 192k | $361k | 9% | Dec 2024 |
|
| Bridgeway Capital Management | 181k | $341k | -1% | Dec 2024 |
|
| Morgan Stanley | 170k | $306k | 295% | Dec 2024 |
|
| Jane Street | 114k | $214k | 147% | Dec 2024 |
|
| Marshall Wace | 102k | $192k | 100% | Dec 2024 |
|
| Squarepoint Ops | 74k | $139k | 33% | Dec 2024 |
|
| Orin Green Financial | 72k | $135k | 0% | Dec 2024 |
|
| Point72 Asia | 54k | $101k | 14% | Dec 2024 |
|
| Commonwealth Equity Services | 50k | $94k | 0% | Dec 2024 |
|
| Goldman Sachs Group | 50k | $94k | -1% | Dec 2024 |
|
| Hsbc Holdings | 40k | $76k | 0% | Dec 2024 |
|
| Prudential Financial | 36k | $68k | 100% | Dec 2024 |
|
| Barclays | 34k | $69k | 0% | Dec 2024 |
|
| Virtu Financial | 34k | $64k | -21% | Dec 2024 |
|
| Bank of America Corporation | 34k | $63k | -25% | Dec 2024 |
|
| Cubist Systematic Strategies | 29k | $55k | 24% | Dec 2024 |
|
| Capital Performance Advisors | 26k | $49k | 0% | Dec 2024 |
|
| Qube Research & Technologies | 25k | $47k | -32% | Dec 2024 |
|
| Aptus Capital Advisors | 23k | $44k | 5% | Dec 2024 |
|
| PFG Investments | 21k | $39k | 100% | Dec 2024 |
|
| Y-Intercept | 19k | $35k | 100% | Dec 2024 |
|
| UBS Group | 18k | $34k | 6125% | Dec 2024 |
|
| Lido Advisors | 16k | $29k | 0% | Dec 2024 |
|
| Kestra Advisory Services | 14k | $26k | -12% | Dec 2024 |
|
| Altshuler Shaham | 12k | $23k | 0% | Dec 2024 |
|
| Catalyst Funds Management Pty | 10k | $19k | 100% | Dec 2024 |
|
| Harbour Investment Management | 10k | $19k | 0% | Dec 2024 |
|
| TD Waterhouse Canada | 6.0k | $11k | 0% | Dec 2024 |
|
| Truvestments Capital | 2.5k | $4.6k | 0% | Dec 2024 |
|
| Jpmorgan Chase & Co | 1.6k | $3.0k | 0% | Dec 2024 |
|
| Lazard Asset Management | 1.3k | $2.0k | 100% | Dec 2024 |
|
| Point72 | 901.00 | $1.7k | -92% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 716.00 | $1.3k | 100% | Dec 2024 |
|
| Group One Trading | 656.00 | $1.2k | 100% | Dec 2024 |
|
| Citigroup | 632.00 | $1.2k | 100% | Dec 2024 |
|
| Activest Wealth Management | 300.00 | $564.000000 | 0% | Dec 2024 |
|
| Federation des caisses Desjardins du Quebec | 250.00 | $470.000000 | 0% | Dec 2024 |
|
| Y.D. More Investments | 220.00 | $413.996000 | 0% | Dec 2024 |
|
| Advisor Group Holdings | 200.00 | $204.000000 | 0% | Dec 2024 |
|
| SRS Capital Advisors | 39.00 | $73.998600 | 0% | Dec 2024 |
|
Who sold out of Protalix Biotherapeutics?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
|---|---|---|---|
| Susquehanna International | Sep 2024 | 84k | $86k |
| Sanctuary Advisors | Sep 2024 | 37k | $63k |
| XTX Topco | Sep 2024 | 35k | $36k |
| National Bank Of Canada /fi/ | Sep 2024 | 6.0k | $6.1k |
| Tower Research Capital | Sep 2024 | 5.1k | $5.2k |
| Simplex Trading | Sep 2024 | 3.4k | $3.0k |